Labcorp Announces 2025 Third Quarter Results

About this update from Labcorp Holdings Inc.

[{"type":"text","content":"Updates Full-Year Guidance","length":26,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Financial results from Operations for third quarter 2025 versus third quarter 2024:","length":83,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue: $3.56 billion versus $3.28 billion","length":43,"tagName":"p"}]},{"val":[{"type":"text","content":"Diluted EPS: $3.12 versus $2.00","length":31,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EPS: $4.18 versus $3.50","length":32,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":106,"olType":false}]},{"val":[{"type":"text","content":"Updated Full-Year Enterprise Revenue, Adjusted EPS and Free Cash Flow guidance:","length":79,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue guidance of 7.4% to 8.0%; midpoint lowered 40 bps due to currency and acquisition timing","length":96,"tagName":"p"}]},{"val":[{"type":"text","content":"Adjusted EPS range of $16.15 to $16.50; midpoint raised by $0.05","length":64,"tagName":"p"}]},{"val":[{"type":"text","content":"Free Cash Flow range of $1.17 billion to $1.29 billion; midpoint raised by $25 million","length":86,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":246,"olType":false}]},{"val":[{"type":"text","content":"Signed several strategic agreements with health systems and regional/local laboratories","length":87,"tagName":"p"}]},{"val":[{"type":"text","content":"Advanced business in high-growth specialty testing areas, including oncology and neurology","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"Introduced Labcorp Test Finder and new digital pathology, cytology and microbiology capabilities","length":96,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":787,"olType":false},{"type":"text","content":"BURLINGTON, N.C., Oct. 28, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the third quarter ended September 30, 2025 and updated full-year guidance.","length":239,"tagName":"p"},{"type":"image","alt":"Labcorp Logo (PRNewsfoto/Labcorp)","displaySize":"","headline":null,"caption":"Labcorp Logo (PRNewsfoto/Labcorp)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":107,"url":"https:...

More updates from Labcorp Holdings Inc.